SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-140525
Filing Date
2024-05-16
Accepted
2024-05-16 16:06:02
Documents
13
Period of Report
2024-05-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d813751d8k.htm   iXBRL 8-K 21295
  Complete submission text file 0001193125-24-140525.txt   142192

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA scph-20240516.xsd EX-101.SCH 2880
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20240516_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20240516_pre.xml EX-101.PRE 11281
16 EXTRACTED XBRL INSTANCE DOCUMENT d813751d8k_htm.xml XML 3633
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 24955520
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)